Reduced activity of SKCa and Na-K ATPase underlies the accelerated impairment of EDH-type relaxations in mesenteric arteries of aging spontaneously hypertensive rats by Gao, YS et al.
Title
Reduced activity of SKCa and Na-K ATPase underlies the
accelerated impairment of EDH-type relaxations in mesenteric
arteries of aging spontaneously hypertensive rats
Author(s) KONG, WCB; Man, RYK; Gao, YS; Vanhoutte, PMGR; Leung,SWS
Citation Pharmacology Research & Perspectives, 2015, v. 3 n. 3, articleno. e00150
Issued Date 2015
URL http://hdl.handle.net/10722/214456
Rights Creative Commons: Attribution 3.0 Hong Kong License
ORIGINAL ARTICLE
Reduced activity of SKCa and Na-K ATPase underlies the
accelerated impairment of EDH-type relaxations in
mesenteric arteries of aging spontaneously hypertensive
rats
Billy W. C. Kong1, Ricky Y. K. Man1, Yuansheng Gao2, Paul M. Vanhoutte1 & Susan W. S. Leung1
1Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
2Department of Physiology and Pathophysiology, Peking University Health Science Center, Beijing, China
Keywords
Aging, endothelial dysfunction, endothelium-
derived hyperpolarization, hypertension,
small-conductance calcium-activated
potassium channel, sodium–potassium
ATPase.
Correspondence
Susan W.S. Leung, Department of
Pharmacology and Pharmacy, 2/F Laboratory
Block, Faculty of Medicine Building, 21
Sassoon Road, Pokfulam, Hong Kong SAR,
China. Tel: (852) 3917 9252; Fax: (852) 2817
0859; E-mail: swsleung@hku.hk
Funding Information
This study was supported by Research Grant
Council General Research Fund
(HKU769907M; HKU769808), Hong Kong
SAR.
Received: 2 April 2015; Accepted: 16 April
2015
Pharma Res Per, 3(3), 2015, e00150,
doi: 10.1002/prp2.150
doi: 10.1002/prp2.150
Abstract
Aging is accompanied by endothelial dysfunction due to reduced bioavailability
of nitric oxide (NO) and/or reduced endothelium-dependent hyperpolarizations
(EDH). This study examines the hypothesis that hypertension aggravates the
impairment of EDH-type relaxation due to aging. EDH-type relaxations were
studied in superior mesenteric arteries isolated from Wistar Kyoto (WKY) and
spontaneously hypertensive (SHR) rats of 12, 36, 60, and 72 weeks of age.
EDH-type relaxations in WKY were reduced with aging, and this was associated
with an impairment of the function of small-conductance calcium-activated
potassium channels (SKCa) and sodium-potassium ATPase (Na-K ATPase).
EDH-type relaxation in SHR was smaller than that in WKY arteries, and further
reduction occurred with aging. Pharmacological experiments suggested a
reduced involvement of SKCa and Na-K ATPase and activation of adenosine
monophosphate-activated protein kinase and silent information regulator T1
(sirtuin-1; SIRT1) in mesenteric arteries of 12-week-old SHR. These pharmaco-
logical findings suggest that in superior mesenteric arteries of the rat, the reduc-
tion in EDH-type relaxation occurs with aging and that such a reduction is
exacerbated in hypertension. The latter exacerbation appears to involve proteins
associated with the process of cellular senescence and is related to impaired
function of SKCa and Na-K ATPase, a phenomenon that is also observed in
mesenteric arteries of older normotensive rats.
Introduction
The endothelium is a monolayer of cells that contributes
to the regulation of vascular tone, inflammation, and
angiogenesis (Feletou and Vanhoutte 2007). The modula-
tion of vascular tone by endothelial cells is accomplished
by vasodilator [mainly nitric oxide (NO) produced by
endothelial NO synthase (eNOS) and endothelium-depen-
dent hyperpolarization (EDH)] and vasoconstrictor
[endothelin-1 and endothelium-derived contracting pro-
stanoids] signals (Furchgott and Vanhoutte 1989; Van-
houtte et al., 2009). The healthy endothelium maintains a
balance between the release of the contracting and relax-
ing factors in response to stimuli such as sheer stress and
endogenous neurohumoral compounds. Abnormality of
endothelial cell function accompanies diseases such as
ischemia, hypertension, atherosclerosis, and diabetes, and
is indeed one of the major predictors of cardiovascular
events (L€uscher et al. 1993; Feletou and Vanhoutte 2007;
Vanhoutte et al., 2009).
Aging has been linked to the development of endothe-
lial senescence, a condition of permanent growth arrest,
and the deterioration of endothelial function resulting
in the alteration of the release of endothelium-derived
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vasoactive substances (Brandes et al. 2005; Csiszar et al.
2008; Erusalimsky 2009). Abnormalities in the morphol-
ogy of endothelial cells, resembling those occurring with
aging, have been demonstrated in experimental hyperten-
sion (Haudenschild et al. 1981). In hypertension, blood
vessels are exposed to increased sheer stress and this
chronic state causes progressive damage to the endothelial
cell layer (Mantelli et al. 1995; Cardillo and Panza 1998).
As such, it appears that chronic exposure to a high-arterial
blood pressure induces and/or accelerates senescence of
endothelial cells. Silent information regulator T1 (SIRT1)
is an important regulator of the process of aging and cel-
lular senescence (Bitterman et al. 2002; Ota et al. 2007;
Donmez and Guarente 2010; Wang et al. 2011). It is a nic-
otinamide adenine dinucleotide-dependent deacetylase
that hydrolyzes lysine residues in various proteins, includ-
ing histones (North and Verdin 2004). Its activation
results in inhibition of senescence (Wang et al. 2011). In
the vasculature, SIRT1 activates eNOS, induces NO pro-
duction and hence promotes endothelium-dependent
relaxation (Mattagajasingh et al. 2007). One of the down-
stream cellular targets of SIRT1 in endothelial cells is
adenosine monophosphate-activated protein kinase
(AMPK; Zu et al. 2010; Wang et al. 2011), which, like
SIRT1, promotes endothelium-dependent relaxations in
the aorta and mesenteric arteries through phosphorylation
of eNOS and hence increased production of NO
(Fisslthaler and Fleming 2009; Ford et al. 2012; Dolinsky
et al. 2013). In addition, genetic deletion of endothelial
AMPK results in high-blood pressure and reduced EDH-
mediated relaxations in mouse mesenteric arteries
(Enkhjargal et al. 2014), suggesting a role of AMPK in
the EDH signaling pathway.
Therefore, this study examines the hypothesis that
hypertension is associated with a more advanced stage of
endothelial dysfunction than natural aging, and that
EDH-type relaxations are impaired at an earlier age in
hypertensive animals compared to normotensive controls.
Moreover, the possible involvements of SIRT1 and AMPK
in the progressive impairment of endothelium-dependent
relaxations were determined in aged and hypertensive
rats. A better understanding of the events underlying the
progression of endothelial dysfunction with aging and its
acceleration by hypertension will facilitate the design of
pharmacological interventions alleviating/preventing vas-
cular complications in the older population.
Materials and Methods
Animals
Male normotensive Wistar-Kyoto (WKY) and spontane-
ously hypertensive (SHR) rats at 12, 36, 60, or 72-week
old (purchased from the Chinese University of Hong
Kong) were used. The animals were housed in a tempera-
ture-controlled room under a 12-h light/12-h dark cycle
and fed with standard laboratory chow and water ad libi-
tum. They were allowed to age under these conditions
starting at the age of 12 weeks. The study was approved
by the committee on the use of live animals in teaching
and research of the University of Hong Kong.
Isolation of mesenteric artery
The rats were anesthetized with pentobarbital sodium
(70 mg/ml/kg; Ganes Chemicals Inc., Pennsville, NJ). At
the time of sacrifice, their arterial blood pressure was
measured by means of a catheter placed in the carotid
artery and attached to a pressure transducer [P23XL
(Grass Technologies, Warwick, RI, USA)] connected to a
recording physiography [MK IV (Narco Bio-Systems,
Austin, TX, USA)]. The superior mesenteric artery was
excised quickly, cleared of adhering tissue and kept in
Krebs-Ringer bicarbonate buffer (control solution) of the
following composition (in 103 M): NaCl (118), KCl
(4.7), CaCl2 (2.5), MgSO4 (1.2), KH2PO4 (1.2), NaHCO3
(25), and glucose (11.1).
Measurement of isometric tension
The arteries were cut into rings (approximately 2 mm in
length) which were suspended in 5-ml organ chambers
for the measurement of isometric tension. The changes
in tension were detected by means of a strain gauge
(MLT0201; AD Instruments, Sydney, Australia) con-
nected to an Octal Bridge Amplifier (ML228; AD Instru-
ments) and recorded with a data acquisition system
(PowerLab@ 8/30; AD Instruments). The rings were
allowed to equilibrate in oxygenated (95% O2/5% CO2)
control solution at 37°C for 90 minutes under a resting
tension of 1 g, which was the optimal basal tension for
rat mesenteric arteries as determined in preliminary
experiments (data not shown). They then were exposed
to potassium chloride (6 9 102 M) to obtain a refer-
ence contraction. To confirm the presence of the endo-
thelium, the rings were contracted with phenylephrine
(106 M) first and then exposed to acetylcholine
(106 M). In isolated arteries of the rat, in particular of
the SHR, the endothelium-dependent relaxations to ace-
tylcholine are blunted by the concomitant release of
endothelium-derived vasoconstrictor prostanoids
(L€uscher and Vanhoutte 1986; Takase et al. 1994; Lang
et al. 1995; Gluais et al. 2005b; Wong et al. 2010; Li
et al. 2011); to avoid this confounding factor all experi-
ments were performed in the presence of the cyclooxy-
genase inhibitor indomethacin (105 M).
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To study EDH-type responses, quiescent rings were incu-
bated with Nx-nitro-L-arginine methyl ester (L-NAME,
NO synthase inhibitor, 104 M) and indomethacin for
30 minutes (Tang et al. 2005; Yeung et al. 2013). Some
preparations were treated with various pharmacological
agents, including 1-[(2-chlorophenyl)diphenylmethyl]-1H-
pyrazole [TRAM-34, intermediate-conductance calcium-
activated potassium (IKCa) channel blocker, 5 9 10
7 M
(Zou et al. 2010; Yeung et al. 2013)], 6,12,19,20,25,26-
hexahydro-5,27:13,18:21,24-trietheno-11,7-metheno-7H-
dibenzo[b,m][1,5,12,16]tetraazacyclotricosine-5,13-diium
ditrifluoroacetate hydrate [UCL 1684, small-conductance
calcium-activated potassium (SKCa) channel blocker,
5 9 107 M (Zou et al. 2010; Yeung et al. 2013)], ouabain
[sodium-potassium ATPase (Na-K ATPase) inhibitor,
103 M (Doughty et al. 2000)], barium chloride [inwardly-
rectifying potassium (KIR) channel blocker, 3 9 10
5 M
(Doughty et al. 2000)], compound C [AMPK inhibitor,
105 M (Thors et al. 2008)] and 6-chloro-2,3,4,9-tetrahy-
dro-1H-carbazole-1-carboxamide [EX-527, selective silent
information regulator T1 (SIRT1) inhibitor, 106 M (Or-
ecchia et al. 2011)] for 40 minutes before evoking contrac-
tions with phenylephrine (EC80). Concentration-relaxation
curves to the endothelium-dependent vasodilator acetyl-
choline (Furchgott and Zawadzki 1980) were obtained by
cumulative additions (from 109 to 104 M) to the organ
chamber. The concentrations of pharmacological inhibitors
used were selected either from previous experience in the
laboratory or from the literature.
Materials
Acetylcholine chloride, barium chloride, compound C, EX-
527, indomethacin, L-NAME, ouabain, phenylephrine,
TRAM-34, and UCL 1684 were purchased from Sigma
(Saint Louis, MO, USA). All drugs were dissolved in dis-
tilled water except for indomethacin, TRAM-34 and UCL
1684 which were dissolved in dimethyl sulfoxide (DMSO).
The final concentration of DMSO in the bath solution was
equal to or less than 0.1%. All concentrations are expressed
as final molar concentrations in the organ chambers.
Statistical analysis
Relaxations to acetylcholine are expressed as percent
reversion of the sustained contraction induced by phenyl-
ephrine. Data are presented as means  standard error of
the mean (SEM). Statistical analysis was performed using
the Prism version5 (GraphPad Software, San Diego, CA,
USA): concentration-response curves of acetylcholine
were compared with two-way analysis of variance fol-
lowed by the Bonferroni post hoc test for multiple
comparisons; whereas Student’s t-test was used for com-
parison between blood pressures of age-matched WKY
and SHR. P values less than 0.05 were considered to indi-
cate statistically significant differences.
Results
The WKY remained normotensive at all ages while the
SHR became hypertensive from 12 weeks on (Fig. 1). As
they aged, there was no significant difference in weight
between the WKY and the SHR (Table 1).
Endothelium-dependent NO-mediated
relaxations
In mesenteric arteries isolated from WKY, acetylcholine-
induced relaxations in the presence of indomethacin
(105 M) alone (Fig. 2, Upper Left) or in that of the combi-
nation of TRAM-34 [IKCa channel blocker, 5 9 10
7 M
(Zou et al. 2010)] plus UCL 1684 [SKCa channel blocker,
5 9 107 M (Zou et al. 2010)] were similar among the dif-
ferent age groups (Fig. 2, Upper Right). However, in SHR
arteries, acetylcholine-induced relaxations in the presence of
indomethacin decreased with aging (Fig. 2, Lower Left). In
the presence of indomethacin, TRAM-34 and UCL 1684, full
relaxation in response to acetylcholine was observed in arter-
ies of 12-week-old SHR, and this relaxation was reduced in
60- and 72-weeks-old SHR (Fig. 2, Lower Right).
EDH-type relaxations
In the presence of indomethacin (105 M) and L-NAME
(104 M), relaxations to acetylcholine in mesenteric arter-
ies of WKY were impaired significantly in an age-depen-
dent manner (Fig. 3, Upper). Acetylcholine-induced
relaxations in the presence of L-NAME and indomethacin
were impaired in mesenteric arteries of 36-week-old SHR
and abolished in those of 72-week-old SHR (Fig. 3,
Lower).
Figure 1. Mean arterial blood pressure of WKY and SHR at different
ages. Values are means  SEM of nine experiments. * P < 0.05
compared with corresponding WKY groups.
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Changes in IKCa- and SKCa-mediated
relaxations in aging and hypertension
In mesenteric arteries of 12-week-old WKY, TRAM-34
(5 9 107 M) or UCL 1684 (5 9 107 M) alone did not
affect the non-NO-non-prostaglandin-mediated relax-
ations (Fig. 4, Upper Left). In 12-week-old SHR, the part
of EDH-type relaxation in the presence of TRAM-34
(mediated by SKCa) was decreased significantly while that
in the presence of UCL 1684 (mediated by IKCa) was not
altered significantly (Fig. 4, Upper Right).
In mesenteric arteries of 36-week-old WKY and SHR,
UCL 1684 alone did not alter acetylcholine-induced
relaxations in the presence of indomethacin and L-NAME
(Fig. 4, Lower Left and Lower Right). In the presence of
TRAM-34, EDH-type relaxations were reduced signifi-
cantly in preparations of 36-week-old WKY compared
with those in arteries of 12-week-old animals (Fig. 4).
Role of Na-K ATPase and KIR in EDH-type
relaxations
Ouabain [Na-K ATPase inhibitor, 103 M (Doughty et al.
2000)], but not barium chloride [KIR channel blocker,
3 9 105 M (Doughty et al. 2000)], abolished the
acetylcholine-induced relaxation in the presence of
Table 1. Body weight (g) in control and hypertensive rats of different ages.
Age (weeks) 12 36 60 72
Control rats (WKY) 310.0  23.5 404.6  20.5 460.8  28.1 490.6  17.3
Hypertensive rats (SHR) 301.1  11.9 410.9  19.3 449.1  26.9 482.9  16.1
Values are means  SEM of nine animals.
Figure 2. Acetylcholine-induced relaxations of superior mesenteric arteries of (Upper) WKY and (Lower) SHR at various ages in the presence of
(Left) indomethacin (cyclooxygenase inhibitor; 105 mol/L) or (Right) indomethacin (105 mol/L) alone, TRAM-34 (IKCa inhibitor; 5 9 10
7 mol/L)
and UCL 1684 (SKCa inhibitor; 5 9 10
7 mol/L). Values are means  SEM of six to eight experiments. *P < 0.05 compared with corresponding
12-week-old groups.
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indomethacin and L-NAME in arteries of 12-week-old
WKY (Fig. 5, Upper Left).
Ouabain alone also abolished EDH-type relaxations in
arteries of 12-week-old SHR (Fig. 5, Upper Right). While
barium chloride alone had no effect on this relaxation in
arteries from 12-week-old WKY, it abolished it in prepa-
rations from SHR of the same age (Fig. 5, Upper Left and
Upper Right).
In 36-week-old WKY mesenteric arteries, acetylcholine-
induced relaxations were inhibited by both ouabain and
barium chloride (Fig. 5, Lower Left), although in younger
age group (12 weeks), only ouabain, but not barium chlo-
ride, inhibited the response (Fig. 5, Upper Left). Inhibi-
tions of the EDH-type relaxations by either ouabain or
barium chloride were also observed in arteries of both
12–week- and 36-week-old SHR (Fig. 5, Upper and Lower
Right).
Role of SIRT-1 and AMPK in EDH-type
relaxations
In the presence of indomethacin and L-NAME, EX-527
[SIRT1 inhibitor, 106 M (Orecchia et al. 2011)] or com-
pound C [AMPK inhibitor, 105 M (Thors et al. 2008)]
significantly inhibited acetylcholine-induced relaxation in
mesenteric arteries of 12-week-old SHR but not in those
of age-matched WKY (Figs. 6, 7).
Discussion
This study determined the effect of aging, with or without
concurrent hypertension on endothelium-dependent
relaxations in the rat mesenteric artery. In normotensive
rats, aging did not reduce acetylcholine-induced, endothe-
lium-dependent relaxations under control conditions. In
arteries of young [12-week old] hypertensive rats, endo-
thelium-dependent relaxations were still comparable to
those observed in preparations of normotensive animals
of the same age. However, as hypertensive rats aged, their
overall endothelium-dependent relaxations decreased, sug-
gesting that aging, when accompanied by hypertension, is
associated with severe endothelial dysfunction in the mes-
enteric artery. This severe endothelial dysfunction could
be attributed mainly to the impairment of EDH-type
relaxations, although reduction in responses to endothe-
lium-derived NO was also observed.
Endothelial dysfunction is manifested in part as an
impairment of NO- and EDH-mediated relaxations
(Feletou and Vanhoutte 2006; Vanhoutte et al., 2009).
NO is synthesized by nitric oxide synthase in the endo-
thelium (Palmer et al. 1987; Rees et al. 1990). Under the
present experimental conditions, NO-mediated relaxations
are the part of acetylcholine-induced decreases in tension
that persist in the presence of indomethacin (to prevent
the production of vasoactive prostanoids), TRAM-34 and
UCL 1684 (IKCa and SKCa channel blockers, respectively,
to prevent EDH-mediated responses) and are sensitive to
the inhibitory effect of nitric oxide synthase inhibitor
(e.g. L-NAME). Whereas the mechanism underlying EDH
varies with species and blood vessel type (Chataigneau
et al. 1998; Chaytor et al. 1998; Edwards et al. 1998; Fis-
slthaler et al. 1999; Morikawa et al. 2003; Shimokawa and
Morikawa 2005), relaxations that are independent of
either NO or prostanoids and require the activation of
IKCa and SKCa are characteristic of EDH-mediated
responses in rat arteries (Corriu et al. 1996; Chataigneau
et al. 1998; Gluais et al. 2005a,b; Feletou and Vanhoutte
2006; Yeung et al. 2013). Therefore, the residual relax-
ations to acetylcholine observed here in mesenteric arter-
ies incubated with indomethacin and L-NAME can be
attributed to EDH, as they were abolished by the combi-
nation of IKCa and SKCa blockers, TRAM-34 and UCL
1684 (Fig. S1). In this study, a greater impairment of
EDH-type than of NO-mediated relaxation with aging is
observed in the WKY. Similar results were obtained in
SHR mesenteric arteries, in which EDH-type relaxation is
abolished at 72 weeks of age while NO still contributes
Figure 3. Acetylcholine-induced relaxations of superior mesenteric
arteries of (Upper) WKY and (Lower) SHR at various ages in the
presence of indomethacin (cyclooxygenase inhibitor; 105 mol/L) and
L-NAME (nitric oxide synthase inhibitor; 104 mol/L). Values are
means  SEM of six to eight experiments. *P < 0.05 compared with
corresponding 12-week-old groups.
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significantly to acetylcholine-induced relaxation. These
findings suggest that aging alone has minimal effect on
NO-mediated relaxations, unlike on EDH-type responses.
The data also suggest that endothelial dysfunction is not
always associated with a reduced activity of NO, but may
be initiated mainly by a reduced contribution of EDH-
type responses.
Hypertension alone also does not affect NO-mediated
relaxation of the rat mesenteric artery. However, NO-
mediated relaxation decreases in preparations of aged
[60- and 72-week old] SHR, but not in WKY. Thus,
impairment of NO-mediated responses only occurs when
aging is associated with hypertension. By contrast, the sig-
naling pathway involved in EDH-type relaxation is dys-
functional at a younger age in the SHR, and hence at an
earlier stage of hypertension than that for NO-mediated
relaxation. Further increases in the age of SHR exacerbate
this impairment until SHR mesenteric arteries no longer
exhibit EDH-type relaxations at the age of 72 weeks.
These findings are in agreement with an earlier report
demonstrating that, while NO-mediated relaxation was
only slightly impaired, EDH-mediated responses were
completely lost in renal arteries of old (22 months) SHR
(B€ussemaker et al. 2003).
The present data suggest that aging and hypertension
per se do not significantly affect endothelium-dependent
NO-mediated relaxations in rat mesenteric arteries, but
that impairment of NO-mediated responses only occurs
when aging is associated with hypertension. On the other
hand, EDH-type relaxations in mesenteric arteries
decrease with either aging or hypertension, and these
impairments are additive. At the early stage, hypertension
is mostly asymptomatic; nevertheless, the exposure of
endothelial cells to a chronically elevated arterial blood
pressure likely predisposes to endothelial dysfunction
thereby increasing the risk for vascular complications with
aging. Therefore, treatment should be initiated as early as
possible to prevent the progression of endothelial damage.
As impairment occurs selectively in the signaling path-
ways leading to EDH-mediated responses, activation of
Figure 4. Effect of inhibition of intermediate- and small-conductance calcium-activated K+ channels on EDH-type relaxation in (Upper) 12- and
(Lower) 36-week-old (Left) WKY and (Right) SHR superior mesenteric arteries. Arteries were incubated with TRAM-34 (IKCa inhibitor;
5 9 107 mol/L) or UCL 1684 (SKCa inhibitor; 5 9 10
7 mol/L) for 40 min in the presence of indomethacin (cyclooxygenase inhibitor; 105 mol/
L) and L-NAME (nitric oxide synthase inhibitor; 104 mol/L). Values are means  SEM of eight experiments. *P < 0.05 compared to the control.
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other vasodilator mechanisms, for example, those involv-
ing NO-mediated response, would be more effective in
reducing the impact of mechanical stress exerted on
endothelial cells due to the high arterial blood pressure.
Activation of potassium channels is the key feature of
the “classical” EDH pathway, as combination of IKCa and
SKCa inhibitors can abolish EDH-mediated relaxation
(Edwards et al. 1998; Gluais et al. 2005a). However,
Figure 5. Effect of inhibition of Na-K ATPase and inwardly rectifying K+ channels on EDH-type relaxation in (Upper) 12- and (Lower) 36-week-old
(Left) WKY and (Right) SHR superior mesenteric arteries. Arteries were incubated with ouabain (Na-K ATPase inhibitor; 103 mol/L) and/or barium
(KIR inhibitor; 3 9 10
5 mol/L) for 40 min in the presence of indomethacin (cyclooxygenase inhibitor; 105 mol/L) and L-NAME (nitric oxide
synthase inhibitor; 104 mol/L). Values are means  SEM of eight experiments. *P < 0.05 compared to the control.
Figure 6. Effect of inhibition of SIRT1 on EDH-type relaxation in 12-week-old (Left) WKY and (Right) SHR superior mesenteric arteries. Arteries
were incubated with EX-527 (SIRT1 inhibitor; 106 mol/L) for 40 min in the presence of indomethacin (cyclooxygenase inhibitor; 105 mol/L) and
L-NAME (nitric oxide synthase inhibitor; 104 mol/L). Values are means  SEM of six experiments. *P < 0.05 compared to the control.
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inhibition of either one of these potassium channels alone
does not affect EDH-type responses in superior mesen-
teric arteries of the young (12-week old) WKY, as
reported in the small (third order branch) mesenteric
artery (Waldron and Garland 1994). The present experi-
ments demonstrate that both aging and hypertension per
se result in a significant impairment of SKCa-mediated
relaxation in superior mesenteric arteries. On the other
hand, IKCa-mediated relaxations in this artery are less sus-
ceptible to the effect of aging and/or hypertension, sug-
gesting a predominant role of IKCa in the EDH pathway
(Giachini et al. 2009). Reduced SKCa-mediated relaxations
in aging [young versus old WKY] or hypertension [young
WKY versus young SHR] alone may be due to reduced
protein expression or reduced activity of SKCa. An earlier
report demonstrating a significant reduction of SKCa
expression in aged hypertensive animals (Weston et al.
2010) suggests that the contribution of SKCa to relaxation
may indeed be impaired due to down-regulation.
Activation of Na-K ATPase and opening of KIR chan-
nels are two of the major mechanisms responsible for the
EDH of vascular smooth muscle cells (Edwards et al.
1998). They act as the downstream signaling pathways of
the IKCa and SKCa, respectively, to facilitate hyperpolar-
ization of the vascular smooth muscle and hence their
relaxation (Dora and Garland 2001; Edwards et al. 2010;
Weston et al. 2010). Indeed, SKCa and IKCa generate
EDH through two distinct pathways: SKCa triggers myo-
cyte hyperpolarization via activation of KIR in caveolae,
whereas IKCa activates the downstream Na-K ATPase in
myoendothelial projections (Weston et al. 2010). The
finding that ouabain, but not barium chloride, abolished
the EDH-type relaxations in arteries of 12-week-old WKY
suggests that, in young WKY, Na-K ATPase plays a
Figure 7. Effect of the inhibition of adenosine monophospate-actived protein kinase (AMPK) on EDH-type relaxation in 12-week-old (Left) WKY
and (Right) SHR superior mesenteric arteries. Arteries were incubated with compound C (AMPK inhibitor; 105 mol/L) for 40 min in the presence
of indomethacin (cyclooxygenase inhibitor; 105 mol/L) and L-NAME (nitric oxide synthase inhibitor; 104 mol/L). Values are means  SEM of six
experiments. *P < 0.05 compared to the control.
Figure 8. The mechanism underlying the impairment of
endothelium-dependent hyperpolarization (EDH)-type relaxations in
aging or hypertensive rats. Aging or hypertension causes the
dysfunction of small-conductance calcium-activated potassium
chanels (SKCa) and sodium-potassium ATPase (Na-K ATPase), thus
impairing EDH-mediated responses. In young hypertensive animals,
the impairment is compensated by the facilitation of the activity
of intermediate-conductance calcium-activated potassium chanels
(IKCa), and the activation of adenosine monophosphate-activated
protein kinase (AMPK) and silent information regulator T1 (sirtuin-1;
SIRT1).
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dominant role in EDH-type response. By contrast, in
arteries of aging and hypertensive animals, EDH-type
relaxation is abolished not only by inhibition of Na-K
ATPase alone, but also by inhibition of KIR alone. Thus,
KIR may serve as a compensatory mechanism for EDH-
type relaxation in mesenteric arteries of aging and hyper-
tensive rats.
In this study, inhibition of SIRT1 did not affect the
EDH-type relaxation in the mesenteric arteries of normo-
tensive rats; however, it reduced that in SHR preparations.
These data suggest that SIRT1 is activated and contributes
to EDH-type relaxations only under the latter pathological
condition. Activation of SIRT1 is regulated by AMPK, and
SIRT1 also activates AMPK (Zu et al. 2010; Wang et al.
2011). As with inhibition of SIRT1, inhibition of AMPK
also reduced EDH-type relaxations in SHR mesenteric
arteries, without affecting such responses in WKY prepara-
tions. The involvement of SIRT1 and AMPK in EDH-type
relaxations in mesenteric arteries of hypertensive, but not
normotensive, rats suggests the development of accelerated
senescence in hypertensive blood vessels. The present find-
ings then indicate that at the early stage of hypertension,
AMPK restores EDH-mediated relaxations. These findings
are in line with the reports that the protein expression of
AMPK increases in mesenteric arteries of SHR at 20 to
24 weeks of age (Ford et al. 2012) and that mice deficient
in endothelial AMPK have high-blood pressure and exhi-
bit reduced EDH-like responses in their mesenteric arter-
ies (Enkhjargal et al. 2014). Activation of AMPK leads to
up-regulation of the anti-oxidative enzyme, heme oxygen-
ase-1 (Li et al. 2012, 2013), which in hypertension may
counteract the increased production of reactive oxygen
species that contributes to the impairment of EDH-medi-
ated relaxation (Li et al. 2013; Rashid et al. 2014). A
caveat is that compound C, at the concentration used in
the present experiments, only preferentially inhibits
AMPK, but also competes for the ATP binding sites of
other enzymes (Bain et al. 2007). Therefore, the interpre-
tation based on the use of this pharmacological inhibitor
warrants further investigation.
In conclusion, the present data suggest that EDH-type
response in the rat mesenteric artery undergoes an age-
dependent impairment, which is also observed in hyper-
tensive rats but is exacerbated when aging is associated
with hypertension. The impairment due to aging or
hypertension can be attributed to reduced involvement of
SKCa (Fig. 8), suggesting that high arterial blood pressure
may cause similar damage to endothelial function as
aging. The remaining EDH-type relaxation in young
hypertensive animal appears to depend on the activation
of SIRT1 and AMPK, which may serve to combat the
impairment of endothelium-dependent relaxation in
hypertension.
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Figure S1. Acetylcholine-induced relaxations of superior
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